Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4N5 liposome lotion for actinic keratoses in xeroderma pigmentosum
NCT00002811Phase 3Unknown
- Sponsor
- Applied Genetic Technologies Corporation
- Start
- Jul 1996
- Modality
- Therapeutic Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of T4 endonuclease V liposomal lotion in actinic keratosis (AK), basal cell carcinoma (BCC), sponsored by Applied Genetic Technologies Corporation. Status: unknown.
02
Drugs
T4 endonuclease V liposomal lotion
03
Conditions
actinic keratosis (AK)basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00002811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002811.